Sobril is a short-acting benzodiazepine. It raises neuronal membrane permeability to Cl ions by binding to stereospecific benzodiazepine receptors within the postsynaptic GABA neuron w/in the CNS (including the limbic program, reticular development) and enhancing the GABA inhibitory effects leading to hyperpolarisation and stabilisation. Signs o